MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 62 filers reported holding MARRONE BIO INNOVATIONS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $15,000 | 0.0% | 12,641 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +36.4% | 12,641 | -3.1% | 0.00% | – |
| Q1 2020 | $11,000 | -15.4% | 13,041 | 0.0% | 0.00% | – |
| Q4 2019 | $13,000 | -27.8% | 13,041 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -18.2% | 13,041 | -10.9% | 0.00% | – |
| Q2 2019 | $22,000 | -4.3% | 14,641 | -3.8% | 0.00% | – |
| Q1 2019 | $23,000 | +43.8% | 15,224 | +37.6% | 0.00% | – |
| Q4 2018 | $16,000 | -20.0% | 11,061 | 0.0% | 0.00% | – |
| Q3 2018 | $20,000 | 0.0% | 11,061 | 0.0% | 0.00% | – |
| Q2 2018 | $20,000 | -9.1% | 11,061 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | +83.3% | 11,061 | 0.0% | 0.00% | – |
| Q4 2017 | $12,000 | -33.3% | 11,061 | -31.1% | 0.00% | – |
| Q3 2017 | $18,000 | -18.2% | 16,061 | -5.3% | 0.00% | – |
| Q2 2017 | $22,000 | -24.1% | 16,961 | +13.4% | 0.00% | – |
| Q1 2017 | $29,000 | -43.1% | 14,961 | -37.7% | 0.00% | – |
| Q4 2016 | $51,000 | – | 24,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 18,335,767 | $21,269,000 | 3.50% |
| OAK FAMILY ADVISORS, LLC | 895,873 | $1,039,000 | 0.52% |
| Shay Capital LLC | 2,145,580 | $2,489,000 | 0.50% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 2,002,214 | $2,323,000 | 0.47% |
| EHP Funds Inc. | 956,381 | $1,109,000 | 0.18% |
| Alpine Global Management, LLC | 524,318 | $608,000 | 0.15% |
| Ergoteles LLC | 1,360,987 | $1,579,000 | 0.05% |
| Clear Harbor Asset Management, LLC | 243,671 | $283,000 | 0.04% |
| Diametric Capital, LP | 22,590 | $26,000 | 0.02% |
| FNY Investment Advisers, LLC | 20,000 | $23,000 | 0.02% |